Mid Continent Capital’s Eli Lilly LLY Stock Holding History

Mid Continent Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$387K	Buy	4,625 +1,000	+28%	+$84.4K	0.03%	220
2015 Q2	$303K	Hold	3,625	–	–	0.02%	266
2015 Q1	$263K	Sell	3,625 -975	-21%	-$69.4K	0.01%	275
2014 Q4	$317K	Hold	4,600	–	–	0.02%	261
2014 Q3	$298K	Hold	4,600	–	–	0.02%	271
2014 Q2	$286K	Sell	4,600 -200	-4%	-$11.9K	0.02%	278
2014 Q1	$283K	Hold	4,800	–	–	0.02%	270
2013 Q4	$245K	Hold	4,800	–	–	0.02%	290
2013 Q3	$241K	Hold	4,800	–	–	0.02%	288
2013 Q2	$236K	Buy	+4,800	New	+$261K	0.02%	280

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mid Continent Capital's LLY Position: Q3 2015 in Review

Mid Continent Capital increased its Eli Lilly (LLY) stake by 28% in Q3 2015, buying an estimated $84.4K and bringing the position to 4,625 shares worth $387K. The position accounts for 0.03% of the portfolio, ranked #220.

Mid Continent Capital first reported a position in LLY in Q2 2013 and has held it in 10 quarters since. 1,148 funds tracked by Wall St. Rank hold LLY as of Q3 2015.

Mid Continent Capital held 4,625 shares of Eli Lilly worth $387K as of Q3 2015.
Mid Continent Capital bought 1,000 Eli Lilly shares in Q3 2015, an estimated $84.4K.
Eli Lilly made up 0.03% of Mid Continent Capital's portfolio in Q3 2015, its #220 holding.
Mid Continent Capital first reported a position in Eli Lilly in Q2 2013 and has held it in 10 quarters since.
1,148 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2015.

Based on Mid Continent Capital's 13F filing for Q3 2015, filed 22 Oct 2015.